DGRO vs XLV
iShares Core Dividend Growth ETF vs Health Care Select Sector SPDR Fund
- • DGRO pays a higher dividend yield (1.95%).
Side-by-side metrics
| Metric | DGRO | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.08% | 0.08% |
Dividend yield Trailing 12-month yield. | 1.95% | 1.60% |
AUM Assets under management — bigger funds are typically more liquid. | $41.23B | $40.60B |
YTD return | 11.68% | 5.74% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.68 | 0.51 |
P/E ratio | 23.50 | 29.18 |
Last price | $76.92 | $162.17 |
Inception | — | — |
Issuer | iShares | State Street |
DGRO top holdings
| JNJ | Johnson & Johnson | 3.12% |
| ABBV | AbbVie Inc | 3.05% |
| JPM | JPMorgan Chase & Co | 3.03% |
| AAPL | Apple Inc | 2.76% |
| MSFT | Microsoft Corp | 2.67% |
| XOM | Exxon Mobil Corp | 2.60% |
| AVGO | Broadcom Inc | 2.55% |
| HD | The Home Depot Inc | 2.33% |
| PG | Procter & Gamble Co | 2.26% |
| PM | Philip Morris International Inc | 2.08% |
XLV top holdings
| LLY | Eli Lilly and Co | 16.48% |
| JNJ | Johnson & Johnson | 10.62% |
| ABBV | AbbVie Inc | 7.72% |
| UNH | UnitedHealth Group Inc | 6.56% |
| MRK | Merck & Co Inc | 5.51% |
| AMGN | Amgen Inc | 3.40% |
| TMO | Thermo Fisher Scientific Inc | 3.24% |
| ABT | Abbott Laboratories | 2.75% |
| GILD | Gilead Sciences Inc | 2.73% |
| ISRG | Intuitive Surgical Inc | 2.45% |
About DGRO
DGRO (iShares Core Dividend Growth ETF) is US stocks with sustained dividend growth. Managed by iShares, the fund carries $41.2B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.95%. Its largest holding is Johnson & Johnson (JNJ), which represents 3.1% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 6.5%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $40.6B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.60%. Its largest holding is Eli Lilly and Co (LLY), which represents 16.5% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.